Clinical Profile and Outcomes of Pulmonary Embolism in Central Iran: A Retrospective Cohort Study

被引:0
作者
Andishmand, Abbas [1 ]
Sharifi, Leila [1 ]
Namayandeh, Seyedeh Mahdieh [1 ]
机构
[1] Shahid Sadoughi Univ Med Sci, Yazd Cardiovasc Res Ctr, Yazd, Iran
关键词
Mortality; Pulmonary embolism; Thrombolytic therapy; Venous thromboembolism; MANAGEMENT; RISK; DIAGNOSIS;
D O I
10.34172/aim.31907
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary embolism (PE) is a significant public health concern. This retrospective cohort study examines the clinical profiles and outcomes of patients diagnosed with PE at a medical center in central Iran, aiming to identify mortality predictors during hospitalization and follow-up. Methods: Data from 109 patients diagnosed with PE were analyzed, with a median follow-up of 23 months. The collected information included demographic and clinical characteristics, laboratory findings, treatment protocols, and outcomes. Logistic regression and Kaplan-Meier survival analysis were used to identify independent mortality predictors and assess survival impact. Results: The mean age was 59.2 years ( +/- 19.7), with 51.4% male. Common symptoms included dyspnea (86%) and chest pain (53%), with non-massive PE being the most prevalent (63%). Independent mortality predictors identified were age (odds ratio [OR] 1.065 per year, P < 0.001), female sex (OR 4.421, P = 0.009), and PE severity (OR 0.262, P = 0.023). Kaplan-Meier analysis showed reduced survival probabilities in females (P = 0.009), those with provoked PE (P = 0.002), patients over 65 (P= 0.016), and individuals with comorbidities (P = 0.018). In-hospital mortality was 10.1%, linked to provoked massive PE, absence of thrombolytic therapy, and reduced left ventricular ejection fraction (LVEF). Conclusion: In this cohort, age, sex, and PE severity were significant mortality predictors, while provoked PE, advanced age, and comorbidities were associated with lower mid-term survival probabilities.
引用
收藏
页码:667 / 673
页数:7
相关论文
共 23 条
[1]   Pulmonary Embolism Response Teams: Theory, Implementation, and Unanswered Questions [J].
Bejjani, Antoine ;
Khairani, Candrika D. ;
Campia, Umberto ;
Piazza, Gregory .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
[2]  
Belohlávek J, 2013, EXP CLIN CARDIOL, V18, P129
[3]   The optimal duration of anticoagulant treatment following pulmonary embolism [J].
Couturaud, F. .
REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (10) :1265-1277
[4]   Pulmonary embolism: update on management and controversies [J].
Duffett, Lisa ;
Castellucci, Lana A. ;
Forgie, Melissa A. .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
[5]   Long-term mortality in patients with pulmonary embolism: results in a single-center registry [J].
Eckelt, Johannes ;
Hobohm, Lukas ;
Merten, Marie C. ;
Pagel, Charlotta F. ;
Eggers, Ann-Sophie ;
Lerchbaumer, Markus H. ;
Stangl, Karl ;
Hasenfuss, Gerd ;
Konstantinides, Stavros ;
Schmidtmann, Irene ;
Lankeit, Mareike ;
Ebner, Matthias .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (05)
[6]   Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation [J].
Hojen, Anette Arbjerg ;
Nielsen, Peter Bronnum ;
Overvad, Thure Filskov ;
Albertsen, Ida Ehlers ;
Klok, Frederikus A. ;
Rolving, Nanna ;
Sogaard, Mette ;
Ording, Anne Gulbech .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
[7]   Pulmonary embolism in United States emergency departments, 2010-2018 [J].
Hsu, Shu-Hsien ;
Ko, Chia-Hsin ;
Chou, Eric H. ;
Herrala, Jeffrey ;
Lu, Tsung-Chien ;
Wang, Chih-Hung ;
Chang, Wei-Tien ;
Huang, Chien-Hua ;
Tsai, Chu-Lin .
SCIENTIFIC REPORTS, 2023, 13 (01)
[8]  
Jin Jill, 2015, JAMA, V314, P98, DOI 10.1001/jama.2015.7431
[9]   The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism [J].
Konstantinides, Stavros V. ;
Meyer, Guy .
EUROPEAN HEART JOURNAL, 2019, 40 (42) :3453-3455
[10]  
Levis Joel T, 2011, Perm J, V15, P75